EXHIBIT 11
CYTOCLONAL PHARMACEUTICS INC.
COMPUTATION OF NET (LOSS) PER COMMON SHARE
(unaudited)
THREE MONTHS SIX MONTHS
ENDED JUNE 30, ENDED JUNE 30,
1998 1997 1998 1997
----------- ----------- ----------- -----------
Net (loss) $(169,000) $(779,000) $ (959,000) $(1,517,000)
Add cumulative preferred dividend (51,000) (73,000) (103,000) (146,000)
--------- --------- ----------- -----------
NET (LOSS) USED FOR COMPUTATION $(220,000) $(852,000) $(1,062,000) $(1,663,000)
Weighted average number of common
shares outstanding - basic and
diluted 9,727,000 8,206,000 9,286,000 8,073,000
----------- -----------
Net (loss) per common share - $ (0.02) $ (0.10) $ (0.11) $ (0.21)
basic and diluted